337 related articles for article (PubMed ID: 28919788)
1. Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?
Menzella F; Galeone C; Bertolini F; Castagnetti C; Facciolongo N
J Asthma Allergy; 2017; 10():237-247. PubMed ID: 28919788
[TBL] [Abstract][Full Text] [Related]
2. Biologics and Bronchial Thermoplasty for severe refractory asthma treatment: From eligibility criteria to real practice. A cross-sectional study.
Menzella F; Galeone C; Ruggiero P; Bagnasco D; Catellani C; Facciolongo N
Pulm Pharmacol Ther; 2020 Feb; 60():101874. PubMed ID: 31857207
[TBL] [Abstract][Full Text] [Related]
3. The clinical profile of benralizumab in the management of severe eosinophilic asthma.
Menzella F; Lusuardi M; Galeone C; Facciolongo N; Zucchi L
Ther Adv Respir Dis; 2016 Dec; 10(6):534-548. PubMed ID: 27612492
[TBL] [Abstract][Full Text] [Related]
4. Molecular Targets for Biological Therapies of Severe Asthma: Focus on Benralizumab and Tezepelumab.
Cheng SL
Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440488
[TBL] [Abstract][Full Text] [Related]
5. Tailored therapy for severe asthma.
Menzella F; Lusuardi M; Galeone C; Zucchi L
Multidiscip Respir Med; 2015; 10(1):1. PubMed ID: 25671117
[TBL] [Abstract][Full Text] [Related]
6. Severe refractory asthma: current treatment options and ongoing research.
Menzella F; Bertolini F; Biava M; Galeone C; Scelfo C; Caminati M
Drugs Context; 2018; 7():212561. PubMed ID: 30534175
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies for the treatment of refractory asthma.
Hambly N; Nair P
Curr Opin Pulm Med; 2014 Jan; 20(1):87-94. PubMed ID: 24275927
[TBL] [Abstract][Full Text] [Related]
8. Biological therapy for severe asthma.
Dragonieri S; Carpagnano GE
Asthma Res Pract; 2021 Aug; 7(1):12. PubMed ID: 34389053
[TBL] [Abstract][Full Text] [Related]
9. Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach.
López-Viña A; Díaz Campos RM; Trisan Alonso A; Melero Moreno C
Front Allergy; 2022; 3():1007593. PubMed ID: 36452259
[TBL] [Abstract][Full Text] [Related]
10. Precision medicine in asthma: the role of bronchial thermoplasty.
Oberle AJ; Mathur P
Curr Opin Pulm Med; 2017 May; 23(3):254-260. PubMed ID: 28319473
[TBL] [Abstract][Full Text] [Related]
11. [Bronchial thermoplasty for asthma treatment].
Çalışkan T; Okutan O; Kartaloğlu Z
Tuberk Toraks; 2018 Jun; 66(2):156-165. PubMed ID: 30246660
[TBL] [Abstract][Full Text] [Related]
12. Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study.
Albers FC; Müllerová H; Gunsoy NB; Shin JY; Nelsen LM; Bradford ES; Cockle SM; Suruki RY
J Asthma; 2018 Feb; 55(2):152-160. PubMed ID: 28622052
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
Giovannini M; Mori F; Barni S; de Martino M; Novembre E
Ital J Pediatr; 2019 Nov; 45(1):151. PubMed ID: 31779657
[TBL] [Abstract][Full Text] [Related]
14. Novel Biological Therapies in Severe Asthma: Targeting the Right Trait.
Varricchi G; Marone G; Spadaro G; Russo M; Granata F; Genovese A; Marone G
Curr Med Chem; 2019; 26(16):2801-2822. PubMed ID: 29318959
[TBL] [Abstract][Full Text] [Related]
15. New Anti-Eosinophil Drugs for Asthma and COPD: Targeting the Trait!
Bel EH; Ten Brinke A
Chest; 2017 Dec; 152(6):1276-1282. PubMed ID: 28583618
[TBL] [Abstract][Full Text] [Related]
16. Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty.
Menzella F; Galeone C; Lusuardi M; Simonazzi A; Castagnetti C; Ruggiero P; Facciolongo N
Ther Clin Risk Manag; 2017; 13():1489-1493. PubMed ID: 29184413
[TBL] [Abstract][Full Text] [Related]
17. Eligibility of monoclonal antibody-based therapy for patients with severe asthma: a Canadian cross-sectional perspective.
Jeimy S; Tsoulis MW; Hachey J; Kim H
Allergy Asthma Clin Immunol; 2018; 14():68. PubMed ID: 30479629
[TBL] [Abstract][Full Text] [Related]
18. Biologics to Treat Severe Asthma in Children and Adolescents: A Practical Update.
Marseglia GL; Licari A; Tosca MA; Ciprandi G
Pediatr Allergy Immunol Pulmonol; 2020 Dec; 33(4):168-176. PubMed ID: 35921565
[No Abstract] [Full Text] [Related]
19. [Biologicals in the Treatment of Bronchial Asthma].
Haasler I; Taube C
Pneumologie; 2017 Oct; 71(10):684-698. PubMed ID: 29017221
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis.
Edris A; De Feyter S; Maes T; Joos G; Lahousse L
Respir Res; 2019 Aug; 20(1):179. PubMed ID: 31395084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
